Home About Press Employ Contact Spyglass Advanced Search
HHMI Logo
HHMI News
HHMI News
Scientists & Research
Scientists & Research
Janelia Farm
Janelia Farm
Grants & Fellowships
Grants & Fellowships
Resources
Resources
HHMI Bulletin
Currrent Issue Subscribe
Back Issues About the Bulletin
August '06
Features
divider
Cech
divider
Up Front
divider

The Secret Life of Plantssmall arrow

divider

The Right Framesmall arrow

divider

Stopping a Force of Nature

divider
Chronicle
divider
Perspectives
divider
Editor

Subscribe Free
Sign up now and receive the HHMI Bulletin by mail free.small arrow

UPFRONT: Stopping a Force of Nature

PAGE 1 OF 2

Stopping a Force of Nature
by Paul Muhlrad

Stopping a Force of Nature

In this model of part of the telomerase enzyme, green highlights the groove that “anchors” it near the chromosome's tip.

Telomeres, the long chains of DNA letters capping the ends of chromosomes, seem like a Dr. Seuss creation. What they spell out, in the language of DNA, amounts to gibberish.

The exact spelling varies from organism to organism but usually consists of repetitions of a single 6- to 10-letter “word.” In human telomeres, the sequence is TTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGG… stretching for thousands of letters.

For all their senseless monotony, telomeres play essential roles in cells and organisms. Without them, the genetic legacy of higher organisms could not endure as it does through countless generations (see sidebar). But that same life sustenance that telomeres breathe into species can also bring death to individual organisms, explains HHMI president Thomas R. Cech, whose laboratory at the University of Colorado studies telomerase, the enzyme that maintains telomeres on chromosomes. “Telomerase is involved in about 90 percent of cancers,” Cech says.

All human cells initially contain telomerase, he explains, but most adult body cells, which typically divide only a limited number of times, lack the enzyme. As those cells age, their telomeres gradually shorten, prompting them to stop growing and senesce. But telomerase becomes reactivated in cancer cells, continually lengthening the telomeres, endowing the cells with immortality and energy-sapping dominion over the body.

Cech's research team recently made a key finding about a crucial piece of the enzyme, called telomerase reverse transcriptase (TERT). Understanding TERT's three-dimensional structure could help scientists develop drugs to turn the renegade enzyme off in cancer cells. But until very recently, attempts to grow crystals of the enzyme, required for solving its structure, had failed. “Lots of labs have been trying to crystallize it since we discovered TERT 9 years ago, but the protein has never been very soluble,” Cech says. When produced in bacteria, the enzyme molecules tend to aggregate into misshapen clumps, called inclusion bodies, which are useless for structural studies.

Image: Courtesy of Steven Jacobs/Cech lab

dividers
PAGE 1 OF 2
Continue small arrow
dividers
Download Story PDF
Requires Adobe Acrobat
Email This Story

HHMI INVESTIGATOR

Thomas R. Cech
Thomas R. Cech
 
Related Links

AT HHMI

bullet icon

Groovy Protein Essential for Promoting Cancer Development
(02.05.06)

bullet icon

Visualizing the End of the Human Genome
(11.21.04)

bullet icon

Life at the End of the Chromosome
(1995 Holiday Lectures on Science)

bullet icon

Cells Aglow
(HHMI Bulletin: Summer 2004)

ON THE WEB

external link icon

Crystal Structure of the TERT TEN domain

external link icon

The 1989 Nobel Prize in Chemistry

dividers
Back to Topto the top
HHMI Logo

Home | About HHMI | Press Room | Employment | Contact

© 2012 Howard Hughes Medical Institute. A philanthropy serving society through biomedical research and science education.
4000 Jones Bridge Road, Chevy Chase, MD 20815-6789 | (301) 215-8500 | e-mail: webmaster@hhmi.org